天然药物成分在抗艾滋病治疗中的研究进展
Advances in the Research of Natural Drugs in Anti-AIDS Treatment
DOI: 10.12677/PI.2022.112011, PDF,   
作者: 郭彦亮*：东南大学化学化工学院，江苏 南京;江苏豪森药业集团有限公司，江苏 连云港；高 彪：江苏豪森药业集团有限公司，江苏 连云港
关键词: 人类免疫缺陷病毒；天然产物；联合疗法；激活和杀灭；抑制潜在宿主；Human Immunodeficiency Virus； Natural Product-Derived Compounds； Combination Antiretroviral Therapy (cART)； Activate and Kill Potential Reservoirs；Suppress Potential Reservoirs
摘要: 本文回顾了艾滋病发病机理和治疗现状，天然药物成分的发现将是在艾滋病治疗中的另一热点。当下对HIV的治疗方案包括抑制病毒复制转录、激活和杀灭潜在宿主、抑制潜在宿主多个策略，本文综述了天然药物成分在以上三个方向的研究进展，并指出存在的问题和发展前景。
Abstract: This paper reviews the pathogenesis and treatment status of AIDS, and natural drug discovery will be another popular topic in AIDS treatment. Current treatment options for HIV include strategies to inhibit viral replication, activate and kill potential reservoirs, and suppress potential reservoirs. This paper summarizes the research progress of natural products in the above three directions and points out the existing problems and development prospects.
文章引用：郭彦亮, 高彪. 天然药物成分在抗艾滋病治疗中的研究进展[J]. 药物资讯, 2022, 11(2): 84-89. https://doi.org/10.12677/PI.2022.112011

参考文献

[1] 史宏博, 董红军, 洪航. 艾滋病精准防控的研究进展[J]. 中国艾滋病性病, 2020, 26(6): 664-666.
[2] 田秋霞, 马玉迪阳, 崔怡然, 宇传华. 中, 美, 日三国艾滋病疾病负担现状及趋势分析[J]. 公共卫生与预防医学, 2021, 32(3): 1-5.
[3] Davenport, M.P., Khoury, D.S., Cromer, D., Lewin, S.R., Kelleher, A.D. and Kent, S.J. (2019) Functional Cure of HIV: The Scale of the Challenge. Nature Reviews Immunology, 19, 45-54. [Google Scholar] [CrossRef] [PubMed]
[4] Kurapati, K.R.V., Atluri, V.S., Samikkannu, T., Garcia, G. and Nair, M.P.N. (2016). Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview. Frontiers in Microbiology, 6, Article No. 1444.[CrossRef] [PubMed]
[5] Deeks, S.G., Overbaugh, J., Phillips, A. and Buchbinder, S. (2015) HIV Infection. Nature Reviews Disease Primers, 1, Article No. 15035. [Google Scholar] [CrossRef] [PubMed]
[6] Moir, S., Chun, T.-W. and Fauci, A.S. (2011). Pathogenic Mechanisms of HIV Disease. Annual Review of Pathology. Mechanisms of Disease, 6, 223-248.[CrossRef] [PubMed]
[7] Günthard, H.F., Aberg, J.A., Eron, J.J., et al. (2014) Antiretroviral Treatment of Adult HIV Infection: 2014 Recommendations of the International Antiviral Society-USA Panel. JAMA, 312, 410-425. [Google Scholar] [CrossRef] [PubMed]
[8] Günthard, H.F., Saag, M.S., Benson, C.A., et al. (2016) Antiretrovi-ral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society—USA Panel. JAMA, 316, 191-210. [Google Scholar] [CrossRef] [PubMed]
[9] Gravatt, L.A.H., Leibrand, C.R., Patel, S. and McRae, M. (2017) New Drugs in the Pipeline for the Treatment of HIV: A Review. Current Infectious Disease Reports, 19, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
[10] 张淼, 于祯钰. 新形势下中医药防治艾滋病的思考[J]. 世界中医药, 2021, 16(8): 1316-1319.
[11] Cary, D.C. and Peterlin, B.M. (2018) Natural Products and HIV/AIDS. AIDS Research and Human Retroviruses, 34, 31-38. [Google Scholar] [CrossRef] [PubMed]
[12] Bahare, S., Nanjangud, K., Şener, B., Sharifi-Rad, M., Kılıç, M., Mahady, G.B., et al. (2018) Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus. International Journal of Molecular Sciences, 19, Article No. 1459. [Google Scholar] [CrossRef] [PubMed]
[13] Andersen, R.J., Ntie-Kang, F. and Tietjen, I. (2018) Natural Prod-uct-Derived Compounds in HIV Suppression, Remission, and Eradication Strategies. Antiviral Research, 158, 63-77. [Google Scholar] [CrossRef] [PubMed]
[14] Kashman, Y., Gustafson, K.R., Fuller, R.W., Cardellina 2nd, J.H., McMahon, J.B., Currens, M.J., et al. (1992) The Calanolides, a Novel HIV-Inhibitory Class of Coumarin Deriva-tives from the Tropical Rainforest Tree, Calophyllum lanigerum. Journal of Medicinal Chemistry, 35, 2735-2743. [Google Scholar] [CrossRef] [PubMed]
[15] Sonar, V.P., Corona, A., Distinto, S., Maccioni, E., Meleddu, R., Fois, B., et al. (2017) Natural Product-Inspired Esters and Amides of Ferulic and Caffeic Acid as Dual Inhibitors of HIV-1 Reverse Transcriptase. European Journal of Medicinal Chemistry, 130, 248-260. [Google Scholar] [CrossRef] [PubMed]
[16] Esposito, F., Tintori, C., Martini, R., Christ, F., Debyser, Z., Ferrarese, R., et al. (2015) Kuwanon-L as a New Allosteric HIV-1integrase Inhibitor: Molecular Modeling and Biologi-cal Evaluation. ChemBioChem, 16, 2507-2512. [Google Scholar] [CrossRef] [PubMed]
[17] Zhang, H.J., Rumschlag-Booms, E., Guan, Y.F., Wang, D.Y., Liu, K.L., Li, W.F., et al. (2017) Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa. Journal of Natural Products, 80, 1798-1807. [Google Scholar] [CrossRef] [PubMed]
[18] Spivak, A.M., Bosque, A., Balch, A.H., Smyth, D., Martins, L. and Planelles, V. (2015) Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4+ T Cells from Aviremic Patients. Antimicrobial Agents and Chemotherapy, 59, 5984-5991 [Google Scholar] [CrossRef] 
[19] Kessing, C.F., Nixon, C.C., Li, C., Tsai, P., Takata, H., Mousseau, G., Ho, P.T., Honeycutt, J.B., Fallahi, M., Trautmann, L., Garcia, J.V. and Valente, S.T. (2017) In Vivo Suppression of HIV Rebound by Didehydrocortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment. Cell Reports, 21, 600-611.
[20] 阮金兰. 天然抗艾滋病药物研究现状与思路[J]. 湖北中医学院学报, 1999(4): 55-56.